SCM
PLSE icon

Sterling Capital Management’s Pulse Biosciences PLSE Stock Holding History

Sterling Capital Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.8K Sell
65
-50
-43% -$1.18K ﹤0.01% 3015
2026
Q1 		$2.48K Hold
115
– – ﹤0.01% 2945
2025
Q4 		$1.58K Buy
115
+72
+167% +$1.12K ﹤0.01% 3094
2025
Q3 		$761 Hold
43
– – ﹤0.01% 3115
2025
Q2 		$649 Buy
43
+24
+126% +$398 ﹤0.01% 3122
2025
Q1 		$306 Hold
19
– – ﹤0.01% 3036
2024
Q4 		$331 Hold
19
– – ﹤0.01% 3075
2024
Q3 		$333 Buy
+19
New +$324 ﹤0.01% 3007

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sterling Capital Management's PLSE Position: Q2 2026 in Review

Sterling Capital Management reduced its Pulse Biosciences (PLSE) stake by 43% in Q2 2026, selling an estimated $1.18K and leaving 65 shares worth $1.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3015.

Sterling Capital Management first reported a position in PLSE in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.48K in Q1 2026. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Sterling Capital Management held 65 shares of Pulse Biosciences worth $1.8K as of Q2 2026.
  • Sterling Capital Management sold 50 Pulse Biosciences shares in Q2 2026, an estimated $1.18K.
  • Pulse Biosciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3015 holding.
  • Sterling Capital Management first reported a position in Pulse Biosciences in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Pulse Biosciences position peaked at $2.48K in Q1 2026.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.